A world-renowned expert with 40+ years and $100M in NIH-funded research. His recent discovery, “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants” earned him global media attention and was published in the Journal of Natural Products.
Ushering in a new era of drug
discovery.
Leveraging Natural Products & AI to Create Superior Drugs
Less than 5% of natural products (NP) have been studied for biological activity. By utilizing NP, we can tap into the vast chemical diversity that nature has to offer, which is often under-explored as a source of drugs.
Our NIH-approved proprietary platform rapidly and efficiently identifies specific interactions between NP and potential drug candidates.
Using data from our AS-MS enables us to quickly and accurately analyze millions of potential drug candidates.
Leveraging Natural Products & AI to Create Superior Drugs
Less than 5% of natural products (NP) have been studied for biological activity. By utilizing NP, we can tap into the vast chemical diversity that nature has to offer, which is often under-explored as a source of drugs.
Our NIH-approved proprietary platform rapidly and efficiently identifies specific interactions between NP and potential drug candidates.
Using data from our AS-MS enables us to quickly and accurately analyze millions of potential drug candidates.
Chief Science Officer & Co-Founder
Prof. Richard van Breemen, PhD.
Chief Science Officer & Co-Founder
Leveraging Natural Products & AI to Create Superior Drugs
A world-renowned expert with 40+ years and $100M in NIH-funded research. His recent discovery, “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants” earned him global media attention and was published in the Journal of Natural Products.
In The Press
Previous
Next
Leadership & Advisors
CEO & Co-Founder
Jacob is our stewarding CEO focused on executing corporate strategies and capital raises. He also is co-founder, CEO, and board member of CHTC Inc, and board member of Iconic Ventures. He is an experienced operator with success in venture capital, hemp, and food & beverage industries, with exits totaling $170 million.
Chief Innovation Officer
Strat provides vision on corporate strategies and working plans. He is founder and former director of the Global Hemp Innovation Center at Oregon State University, raising over $80 million in US grants as the global leader in Cannabis sativa research. His university research and teaching focused on advancing the frontiers of computational systems and AI in natural and biological systems science.
Chair | SAB
Khadija Benlhassan, PhD, has fifteen years of experience in preclinical and clinical international research programs. She has worked in drug discovery at GlaxoSmithKline Research and Development and immunology at DANONE Research Centre.
Contact us.
For all general inquiries, please fill out the form below and someone from our team will get back to you shortly.
Applied Discoveries Inc.
© 2024 Applied Discoveries Inc. All Rights Reserved.